Teladoc Health, Inc. (NYSE: TDOC) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
6.30
+0.02+0.32%
TA
Loading chart...
Snapshot
| Index | - | P/E | - | EPS (ttm) | -0.99 | Insider Own | 1.52% | Shs Outstand | 181.68M | Perf Week | 2.27% |
| Market Cap | 1.14B | Forward P/E | - | EPS next Y | -0.62 | Insider Trans | -3.97% | Shs Float | 180.51M | Perf Month | -5.41% |
| Enterprise Value | 1.40B | PEG | - | EPS next Q | -0.22 | Inst Own | - | Short Float | 14.04% | Perf Quarter | -21.93% |
| Income | -178.00M | P/S | 0.46 | EPS this Y | 13.05% | Inst Trans | - | Short Ratio | 5.40 | Perf Half Y | 14.13% |
| Sales | 2.49B | P/B | 0.87 | EPS next Y | 28.09% | ROA | -6.43% | Short Interest | 25.34M | Perf YTD | -10.00% |
| Book/sh | 7.21 | P/C | 1.48 | EPS next 5Y | - | ROE | -13.08% | 52W High | 9.89 -36.30% | Perf Year | -20.25% |
| Cash/sh | 4.26 | P/FCF | 4.98 | EPS past 3/5Y | - | ROIC | -7.08% | 52W Low | 4.40 43.18% | Perf 3Y | -71.23% |
| Dividend Est. | - | EV/EBITDA | - | Sales past 3/5Y | 1.68% 18.26% | Gross Margin | 73.53% | Volatility | 4.02% 3.61% | Perf 5Y | -95.57% |
| Dividend TTM | - | EV/Sales | 0.56 | EPS Y/Y TTM | 83.13% | Oper. Margin | -6.98% | ATR (14) | 0.28 | Perf 10Y | -66.96% |
| Dividend Ex-Date | - | Quick Ratio | 0.81 | Sales Y/Y TTM | -3.15% | Profit Margin | -7.13% | RSI (14) | 43.06 | Recom | 2.64 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.83 | EPS Q/Q | -10.53% | SMA20 | -0.38% | Beta | 2.10 | Target Price | 8.83 |
| Payout | 0.00% | Debt/Eq | 0.75 | Sales Q/Q | -3.96% | SMA50 | -13.56% | Rel Volume | 1.21 | Prev Close | 6.28 |
| Employees | 5,124 | LT Debt/Eq | 0.74 | Earnings | Oct 28 | SMA200 | -5.21% | Avg Volume | 4.55M | Price | 6.30 |
| IPO Date | Jun 30, 2015 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 15.92% -1.38% | Net Debt/EBITDA | -3.75 | Volume | 5,496,137 | Change | 0.32% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-30-26 | Reiterated | Jefferies | Hold | $9.00 → $8.00 |
| Jul-30-26 | Reiterated | Evercore ISI Group | In Line | $6.00 → $7.50 |
| Jul-21-26 | Reiterated | Canaccord Genuity | Buy | $11 |
| Apr-08-26 | Reiterated | Evercore ISI Group | In Line | $9.00 → $6.00 |
| Mar-10-26 | Upgrade | Deutsche Bank | Hold → Buy | $18 → $11 |
| Feb-26-26 | Reiterated | Stifel Nicolaus | Hold | $8.00 → $6.00 |
| Feb-26-26 | Reiterated | Wells Fargo | Equal Weight | $6.00 |
| Jan-16-26 | Reiterated | Goldman Sachs | Buy | $9.00 → $8.00 |
| Jan-09-26 | Reiterated | Goldman Sachs | Buy | $10 → $9.00 |
| Dec-08-25 | Initiated | Barclays | Equal Weight | $20 → $8.50 |
Latest News· Times ET
Sep-17-26
Sep-17-2603:15PM
07:06AM
Sep-11-26
Sep-11-2611:57PM
03:15PM
Sep-09-26
Sep-08-26
Sep-07-26
Sep-03-26
Sep-03-2612:35PM
Sep-02-26
Sep-01-26
Sep-01-2610:04AM
Aug-31-26
Aug-31-2611:58PM
05:03AM
04:00AM
Teladoc Health Appoints Michael Grasher as Chief Financial Officerglobenewswire.com
Aug-28-26
Aug-27-26
Aug-27-2602:30PM
Company
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,489 | 2,530 | 2,570 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 659 | 772 | 751 | — | — | — | — | — | — | |
| Gross Profit | 1,830 | 1,758 | 1,818 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 1,032 | 1,085 | 1,346 | — | — | — | — | — | — | |
| Research and Development | 271 | 278 | 307 | — | — | — | — | — | — | |
| Other Operating Expense | 701 | 658 | 1,186 | — | — | — | — | — | — | |
| Operating Income | -174 | -263 | -1,021 | — | — | — | — | — | — | |
| Interest Expense | 20 | 20 | 24 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 10 | 47 | 51 | — | — | — | — | — | — | |
| Net Income Before Taxes | -183 | -236 | -994 | — | — | — | — | — | — | |
| Income Taxes | -5 | -35 | 8 | — | — | — | — | — | — | |
| Consolidated Net Income | -178 | -200 | -1,001 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | -178 | -200 | -1,001 | — | — | — | — | — | — | |
| Net Income | -178 | -200 | -1,001 | — | — | — | — | — | — | |
| EPS (Recurring) | -0.99 | -1.14 | -5.87 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.99 | -1.14 | -5.87 | — | — | — | — | — | — | |
| EPS (Diluted) | -0.99 | -1.14 | -5.87 | — | — | — | — | — | — | |
| EBITDA | -70 | 147 | 32 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.46 | 0.49 | 0.60 | — | — | — | — | — | — | |
| Gross Margin | 73.52 | 69.49 | 70.74 | — | — | — | — | — | — | |
| Operating Margin | -6.99 | -10.40 | -39.73 | — | — | — | — | — | — | |
| Net Margin | -7.15 | -7.91 | -38.95 | — | — | — | — | — | — | |
| Shares Outstanding | 180 | 176 | 171 | — | — | — | — | — | — | |
| Market Capitalization | 1,134 | 1,232 | 1,554 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | Sep 11 '26 | Sale | 6.10 | 17,805 | 108,682 | 465,535 | Sep 14 |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | Sep 10 '26 | Option Exercise | 0.00 | 42,802 | 0 | 483,340 | Sep 14 |
| Rodrigues Fernando M. | President of BetterHelp | Sep 03 '26 | Sale | 6.51 | 9,812 | 63,876 | 0 | Sep 03 |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | Sep 02 '26 | Sale | 6.30 | 18,327 | 115,478 | 440,538 | Sep 03 |
| Bliss Kelly | President, U.S. Group Health | Sep 02 '26 | Sale | 6.30 | 7,357 | 46,356 | 92,832 | Sep 03 |
| Rodrigues Fernando M. | President of BetterHelp | Sep 02 '26 | Sale | 6.30 | 5,439 | 34,271 | 9,812 | Sep 03 |
| Nueno Carlos | President, International | Sep 02 '26 | Sale | 6.30 | 6,200 | 39,066 | 64,744 | Sep 03 |
| Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | Sep 02 '26 | Sale | 6.30 | 7,573 | 47,717 | 117,616 | Sep 03 |
| Catapano Joseph Ronald | Chief Accounting Officer | Sep 02 '26 | Sale | 6.30 | 274 | 1,726 | 12,865 | Sep 03 |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | Sep 01 '26 | Option Exercise | 0.00 | 44,243 | 0 | 458,865 | Sep 03 |
| Rodrigues Fernando M. | President of BetterHelp | Sep 01 '26 | Option Exercise | 0.00 | 15,251 | 0 | 15,251 | Sep 03 |
| Bliss Kelly | President, U.S. Group Health | Sep 01 '26 | Option Exercise | 0.00 | 15,311 | 0 | 100,189 | Sep 03 |
| Nueno Carlos | President, International | Sep 01 '26 | Option Exercise | 0.00 | 13,273 | 0 | 70,944 | Sep 03 |
| Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | Sep 01 '26 | Option Exercise | 0.00 | 14,928 | 0 | 125,189 | Sep 03 |
| Catapano Joseph Ronald | Chief Accounting Officer | Sep 01 '26 | Option Exercise | 0.00 | 872 | 0 | 13,139 | Sep 03 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.